Ginette Serrero Selected Research

Ginette Serrero Research Topics

Disease

25	Neoplasms (Cancer) 03/2024 - 01/2003
14	Carcinogenesis 11/2021 - 08/2003
14	Breast Neoplasms (Breast Cancer) 04/2021 - 08/2003
5	Prostatic Neoplasms (Prostate Cancer) 05/2022 - 03/2009
4	Ductal Carcinoma 08/2016 - 07/2006
3	Neoplasm Metastasis (Metastasis) 03/2024 - 08/2003
3	Carcinoma (Carcinomatosis) 05/2018 - 05/2009
2	Frontotemporal Dementia (Semantic Dementia) 03/2024 - 01/2021
2	Inflammation (Inflammations) 01/2021 - 10/2017
2	Lymphoma (Lymphomas) 05/2018 - 10/2017
2	Multiple Myeloma 01/2006 - 06/2003
1	Hepatitis C 11/2021
1	Hepatocellular Carcinoma (Hepatoma) 11/2021
1	Chronic Hepatitis C 11/2021
1	Triple Negative Breast Neoplasms 04/2021
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Disease Progression 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 05/2018
1	Cognitive Dysfunction 05/2018
1	Multiple Sclerosis 01/2017
1	Neuromyelitis Optica (Devic's Disease) 01/2017
1	Lung Neoplasms (Lung Cancer) 11/2016
1	Osteoarthritis 10/2014
1	Rheumatoid Arthritis 10/2014
1	Chronic Obstructive Pulmonary Disease (COPD) 09/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2014
1	Kidney Neoplasms (Kidney Cancer) 05/2009
1	Transitional Cell Carcinoma 05/2009
1	Glioblastoma (Glioblastoma Multiforme) 05/2009
1	Urinary Bladder Neoplasms (Bladder Cancer) 05/2009
1	Wounds and Injuries (Trauma) 03/2009
1	Adenocarcinoma 02/2004
1	Prostatic Intraepithelial Neoplasia 02/2004
1	Ovarian Neoplasms (Ovarian Cancer) 01/2003
1	Ovarian Epithelial Carcinoma 01/2003

Drug/Important Bio-Agent (IBA)

37	ProgranulinsIBA 03/2024 - 01/2003
13	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2021 - 01/2003
8	Glycoproteins (Glycoprotein)IBA 11/2021 - 09/2004
6	Biomarkers (Surrogate Marker)IBA 05/2022 - 03/2009
5	Proteins (Proteins, Gene)FDA Link 03/2024 - 12/2019
4	EnzymesIBA 11/2021 - 09/2014
4	Estrogens (Estrogen)FDA Link 11/2016 - 03/2004
4	Estrogen ReceptorsIBA 08/2016 - 03/2004
2	prostaglandin F2alpha receptorIBA 03/2024 - 01/2021
2	ParaffinIBA 01/2018 - 02/2012
2	Messenger RNA (mRNA)IBA 05/2009 - 03/2009
2	Tamoxifen FDA LinkGeneric 09/2004 - 03/2004
1	daclatasvirIBA 11/2021
1	asunaprevirIBA 11/2021
1	Antiviral Agents (Antivirals)IBA 11/2021
1	Protein Kinases (Protein Kinase)IBA 04/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	AntibodiesIBA 01/2021
1	SaporinsIBA 01/2021
1	Neutralizing AntibodiesIBA 01/2021
1	Extracellular Matrix ProteinsIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Androgen Receptors (Androgen Receptor)IBA 09/2020
1	Formaldehyde (Formol)FDA Link 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2015
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2014
1	ImmunosorbentsIBA 10/2014
1	Progesterone Receptors (Progesterone Receptor)IBA 02/2012
1	Aromatase InhibitorsIBA 06/2011
1	Letrozole (Femara)FDA LinkGeneric 06/2011
1	Aromatase (CYP19)IBA 06/2011
1	Mitogen-Activated Protein KinasesIBA 05/2009
1	Small Interfering RNA (siRNA)IBA 05/2009
1	AndrogensIBA 03/2009
1	Oncogene Proteins (Oncogene Protein)IBA 07/2006
1	Trastuzumab (Herceptin)FDA Link 07/2006
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2006
1	AgarIBA 01/2006
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2004
1	Estradiol (Delestrogen)FDA LinkGeneric 03/2004
1	GranulinsIBA 01/2003
1	RNA (Ribonucleic Acid)IBA 01/2003

Therapy/Procedure

8	Therapeutics 05/2022 - 08/2003
1	Aftercare (After-Treatment) 11/2021
1	Drug Therapy (Chemotherapy) 11/2016
1	Precision Medicine 11/2016
1	Biological Therapy 11/2016